Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Infasurf
Infasurf Image

Infasurf

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Infasurf?

Infasurf is a medication that falls under the category of Respiratory Agents - Misc. It is manufactured by a company called ONY. Infasurf is a natural lung surfactant, which is a substance that helps to reduce surface tension within the lungs. This surfactant plays a crucial role in maintaining the elasticity and stability of the lungs, allowing for proper inflation and deflation during breathing. This medication is primarily used in the treatment of Respiratory Distress Syndrome (RDS) in premature infants. RDS is a condition characterized by insufficient production of lung surfactant in premature babies, leading to breathing difficulties. Infasurf helps to supplement or replace the deficient surfactant, improving lung function and reducing the risk of complications associated with RDS. Infasurf is administered directly into the baby's lungs through a process called endotracheal intubation. This ensures that the medication reaches the areas of the lungs where it is needed. It is important to note that Infasurf should only be used under the guidance and prescription of a healthcare professional experienced in neonatal care. As with any medication, there may be potential side effects or contraindications, so it is important to follow the recommended dosage and monitor the baby closely during treatment.

How to use Infasurf?

Infasurf is a medication in the Respiratory Agents - Misc. class that is used to treat a specific condition called respiratory distress syndrome (RDS) in premature infants. It is manufactured by ONY. To use Infasurf, it is typically administered directly into the lungs through a process called endotracheal instillation. This is done by a healthcare professional, usually in a neonatal intensive care unit (NICU). The medication comes in a pre-filled syringe and is given via a breathing tube that is placed in the infant's windpipe. Before administering Infasurf, the healthcare provider will assess the infant's respiratory status and overall condition. The dosage and frequency of administration will be determined by the healthcare professional based on the specific needs of the infant. It's important to note that Infasurf is a prescription medication and should only be used under the guidance and supervision of a healthcare professional. Following the recommended dosage and administration instructions is crucial for the safe and effective use of this medication.

When using Infasurf, there are several important warnings and precautions to be aware of. This medication, which is a respiratory agent, is typically used for the treatment of respiratory distress syndrome (RDS) in premature infants. Here are some key warnings associated with its use: 1. Allergic reactions: Infasurf may cause allergic reactions in some individuals. It's important to watch for signs of an allergic reaction, such as difficulty breathing, rash, itching, or swelling. If any of these symptoms occur, medical attention should be sought immediately. 2. Lung injury or worsening of respiratory distress syndrome: In some cases, the use of Infasurf may cause lung injury or worsen existing respiratory distress syndrome. This can lead to breathing difficulties and other serious complications. Close monitoring by healthcare professionals is necessary to ensure the safety and effectiveness of the treatment. 3. Bacterial contamination: Infasurf is made from calf lung surfactant extract, and there is a risk of bacterial contamination. Healthcare providers should adhere to sterile procedures during the administration of the medication to minimize this risk. 4. Precautions for administration: Infasurf is administered directly into the lungs through an endotracheal tube. Proper training and experience in neonatal care are essential for the correct administration of this medication. It is important to follow the recommended dosage and administration instructions provided by the healthcare professional. 5. Drug interactions: Infasurf is not known to have any significant interactions with other medications. However, it's always important to inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal supplements, to ensure there are no potential interactions. It is crucial to consult with a healthcare professional for detailed information about the warnings and precautions associated with the use of Infasurf. They can provide personalized advice based on the individual's specific medical condition and needs.

Before taking Infasurf, it's important to be aware of certain warnings and precautions associated with this medication. Here are some key points to keep in mind: 1. Allergic reactions: Some individuals may be allergic to Infasurf or its components. If you have a known allergy to any of the ingredients in this medication, it's crucial to inform your healthcare provider before starting treatment. 2. Lung conditions: Infasurf is specifically indicated for the treatment of respiratory distress syndrome (RDS) in premature infants. It is not intended for use in adults or children with lung conditions other than RDS. 3. Infection risk: Infasurf is derived from cow's lungs and cannot completely eliminate the risk of transmitting infections from animals to humans. To minimize this risk, healthcare providers must follow strict guidelines for preparing and administering the medication. 4. Administration: Infasurf is administered directly into a baby's lungs via a breathing tube. This procedure should only be performed by healthcare professionals experienced in the care of premature infants and in a suitable clinical setting. 5. Monitoring: Close monitoring of the baby's lung function, vital signs, and oxygen levels is necessary during and after Infasurf administration. This ensures appropriate response to the treatment and allows for timely intervention if complications arise. 6. Side effects: Like any medication, Infasurf may cause side effects. Common side effects can include changes in heart rate, oxygen levels, blood pressure, and temperature. It's crucial to promptly report any concerning symptoms to the healthcare provider. Remember, these are general warnings and precautions. Always consult your healthcare provider or pharmacist for specific information related to your situation or if you have any questions or concerns about using Infasurf.

Infasurf is a medication in the Respiratory Agents - Misc. class that is primarily used to treat respiratory distress syndrome (RDS) in premature infants. It is a natural lung surfactant, which helps to keep the air sacs in the lungs open and prevent them from collapsing. As with any medication, Infasurf may cause side effects. However, it's important to note that the potential benefits of this medication typically outweigh the risks. Common side effects may include changes in oxygen levels, bradycardia (low heart rate), apnea (temporary cessation of breathing), and pulmonary hemorrhage (bleeding in the lungs). These side effects are typically temporary and can often be managed or resolved with appropriate medical care. It is crucial to consult with a healthcare professional if you have any concerns about the potential side effects of Infasurf. They will be able to assess the benefits and risks based on the individual patient's specific condition and needs. It is also important to follow the healthcare provider's instructions for administration and monitoring when using this medication.

Infasurf is a medication used to treat respiratory distress syndrome (RDS) in premature infants. It is a natural lung surfactant that helps to improve lung function and prevent or treat breathing difficulties in these infants. The main active ingredient in Infasurf is a natural surfactant derived from calf lung extracts. This surfactant contains a mixture of phospholipids, such as phosphatidylcholine, phosphatidylglycerol, and phosphatidylinositol. These phospholipids help to reduce the surface tension in the lungs and keep the air sacs, known as alveoli, from collapsing. This allows for improved gas exchange and easier breathing. In addition to the surfactant components, Infasurf also contains other ingredients to stabilize and preserve the medication. These ingredients include sodium chloride (salt), glycine (an amino acid), and calcium chloride. They help to maintain the potency and sterility of the product. It's important to note that Infasurf is manufactured by ONY Pharmaceuticals and is only intended for use in premature infants under the supervision of healthcare professionals.

Storage of Infasurf, a respiratory agent medication, should be handled properly to ensure its effectiveness and safety. The medication should be stored at controlled room temperature, typically between 20-25 degrees Celsius (68-77 degrees Fahrenheit). It is important to protect the medication from excessive heat, moisture, and light. Infasurf is typically supplied in individual vials or vials within cartons. It is important to keep the vials sealed until ready for use. Once a vial is opened, the remaining medication should be used within 24 hours. Make sure to follow the manufacturer's instructions and guidelines regarding storage and handling. Additionally, it is crucial to keep Infasurf out of the reach of children and pets. This medication is intended for respiratory use and should not be ingested or administered in any other way. If you have any specific questions or concerns regarding the storage of Infasurf, it is important to consult with your healthcare provider or refer to the medication's package insert for detailed instructions.